IBDEI3F5 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57510,1,3,0)
 ;;=3^Screening for Malig Neop of Vagina
 ;;^UTILITY(U,$J,358.3,57510,1,4,0)
 ;;=4^Z12.72
 ;;^UTILITY(U,$J,358.3,57510,2)
 ;;=^5062691
 ;;^UTILITY(U,$J,358.3,57511,0)
 ;;=Z32.00^^267^2878^52
 ;;^UTILITY(U,$J,358.3,57511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57511,1,3,0)
 ;;=3^Pregnancy Test,Unknown Result
 ;;^UTILITY(U,$J,358.3,57511,1,4,0)
 ;;=4^Z32.00
 ;;^UTILITY(U,$J,358.3,57511,2)
 ;;=^5062848
 ;;^UTILITY(U,$J,358.3,57512,0)
 ;;=N81.10^^267^2878^21
 ;;^UTILITY(U,$J,358.3,57512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57512,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,57512,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,57512,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,57513,0)
 ;;=N81.11^^267^2878^20
 ;;^UTILITY(U,$J,358.3,57513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57513,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,57513,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,57513,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,57514,0)
 ;;=N81.12^^267^2878^19
 ;;^UTILITY(U,$J,358.3,57514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57514,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,57514,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,57514,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,57515,0)
 ;;=N60.31^^267^2878^33
 ;;^UTILITY(U,$J,358.3,57515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57515,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,57515,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,57515,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,57516,0)
 ;;=N60.32^^267^2878^32
 ;;^UTILITY(U,$J,358.3,57516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57516,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,57516,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,57516,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,57517,0)
 ;;=N81.6^^267^2878^53
 ;;^UTILITY(U,$J,358.3,57517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57517,1,3,0)
 ;;=3^Rectocele
 ;;^UTILITY(U,$J,358.3,57517,1,4,0)
 ;;=4^N81.6
 ;;^UTILITY(U,$J,358.3,57517,2)
 ;;=^259590
 ;;^UTILITY(U,$J,358.3,57518,0)
 ;;=I05.8^^267^2879^17
 ;;^UTILITY(U,$J,358.3,57518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57518,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,57518,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,57518,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,57519,0)
 ;;=I10.^^267^2879^9
 ;;^UTILITY(U,$J,358.3,57519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57519,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,57519,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,57519,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,57520,0)
 ;;=I25.2^^267^2879^15
 ;;^UTILITY(U,$J,358.3,57520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57520,1,3,0)
 ;;=3^Old MI
 ;;^UTILITY(U,$J,358.3,57520,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,57520,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,57521,0)
 ;;=I25.10^^267^2879^4
 ;;^UTILITY(U,$J,358.3,57521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57521,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery, w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,57521,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,57521,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,57522,0)
 ;;=I25.810^^267^2879^1
 ;;^UTILITY(U,$J,358.3,57522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57522,1,3,0)
 ;;=3^Atherosclerosis of CABG w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,57522,1,4,0)
 ;;=4^I25.810
 ;;^UTILITY(U,$J,358.3,57522,2)
 ;;=^5007141
 ;;^UTILITY(U,$J,358.3,57523,0)
 ;;=I25.811^^267^2879^3
 ;;^UTILITY(U,$J,358.3,57523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57523,1,3,0)
 ;;=3^Athscl Hrt Disease of Transplanted Hrt w/o Ang Pctrs
